(EYEN) $1.56 has 3 BIG Phase 3 Drugs with next big Phase 3 readout expected in September and NDA resubmission coming in early Q4 ...very attractive biotech here
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.